With Investor Support Thin On The Ground, Unilever Won't Up Bid For GSK Consumer Healthcare

 
• By Tom Gallen

Unilever's decision not to increase its £50bn bid for GSK Consumer Healthcare has been widely welcomed by analysts. But they warn that the aborted move for GSK has damaged investor confidence in Unilever’s management.

Unilever_1200x675
• Source: Shutterstock

More from Europe

More from Geography